Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al
Tendon and Ligament Repair Peptides 2026: Current Research Landscape The tendon and ligament repair peptides 2026 research landscape continues to expand across two main directions: refinement of combination protocol designs (BPC-157 + TB-500 timing, dosing, and duration studies) and emerging research on peptide-plus-conventional-therapy integration (peptides combined with mechanical loading protocols or platelet-rich plasma)
These are only useful in cases of true deficiency, and theres little evidence that they reverse greying in the general population
Starting at 0.25mg weekly for the first four weeks, then increasing to 0.5mg for weeks 5-8, then to 1mg for weeks 9-12, and continuing to step up through 1.7mg and 2.4mg at four-week intervals